SOL SpA

  • Market Cap: N/A
  • Industry: Specialty Chemicals
  • ISIN: IT0001206769
EUR
48.75
-0.05 (-0.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About SOL SpA stock-summary
stock-summary
SOL SpA
Specialty Chemicals
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
Company Coordinates stock-summary
Company Details
Via Borgazzi, 27 , MONZA None : 20900
stock-summary
Tel: 39 039 23961
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Eng. Aldo Fumagalli Romario
Chairman of the Board, Chief Executive Officer
Dr. Marco Annoni
Vice Chairman of the Board, Chief Executive Officer
Dr. Giovanni Annoni
Executive Director
Mr. Giulio Fumagalli Romario
Executive Director
Ms. Maria Annoni
Director
Prisca Fumagalli Romario
Director
Erwin Waltr Rahue
Director
Ms. Maria Boccardo
Independent Director
Ms. Susanna Dorigoni
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
150 Million
(Quarterly Results - Dec 2012)
Net Profit:
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

EUR 4,390 Million ()

stock-summary
P/E

786.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.81%

stock-summary
Debt Equity

0.41

stock-summary
Return on Equity

0.54%

stock-summary
Price to Book

4.14